Fuller & Thaler Asset Management, Inc. Care Dx, Inc. Transaction History
Fuller & Thaler Asset Management, Inc.
- $25 Billion
- Q3 2024
A detailed history of Fuller & Thaler Asset Management, Inc. transactions in Care Dx, Inc. stock. As of the latest transaction made, Fuller & Thaler Asset Management, Inc. holds 22,905 shares of CDNA stock, worth $493,602. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22,905Holding current value
$493,602% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CDNA
# of Institutions
216Shares Held
50.9MCall Options Held
97.3KPut Options Held
43.3K-
Black Rock Inc. New York, NY5.29MShares$114 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.54MShares$97.8 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.15MShares$67.8 Million1.65% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl2.99MShares$64.4 Million0.89% of portfolio
-
State Street Corp Boston, MA2.04MShares$43.9 Million0.0% of portfolio
About CareDx, Inc.
- Ticker CDNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 53,458,100
- Market Cap $1.15B
- Description
- CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...